Skip to content

POstoperative Negative-pressure Incision Therapy Following LIver TRANSplant:a Randomized Controlled Trial

POstoperative Negative-pressure Incision Therapy Following LIver TRANSplant (PONILITRANS Study): a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04039659
Acronym
PONILITRANS
Enrollment
110
Registered
2019-07-31
Start date
2019-02-01
Completion date
2021-07-01
Last updated
2019-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant; Complications

Keywords

wound complications, negative-pressure wound therapy

Brief summary

This study is to evaluate whether the prophylactic use of a negativa pressure therapy device (PICOⓇ) on the closed wound of the liver transplant, reduces the postoperative complications of surgical wounds, compared to the use of dressings conventional postoperative

Detailed description

Postoperative complications of surgical wounds are frequent after surgical procedures, even more in the context of liver transplantation given the necessary immunosuppression, high surgical time, high hospital stay and intensive care, politransfusions, etc. Negative pressure therapy is well established for the treatment of open wounds, its use having been recently indicated on closed surgical wounds. The evidence to justify this intervention is still limited. The objective of our clinical trial is to evaluate whether the prophylactic use of a negative pressure therapy device (PICOⓇ) on the closed wound of the liver transplant, reduces the postoperative complications of surgical wounds, compared to the use of dressings conventional postoperative After signing the informed consent of those patients who meet the inclusion criteria, they will be randomized into two groups to install the PICOⓇ device or conventional dressings on the wound. After 7 days, the PICOⓇ device will be removed and both preoperative and postoperative variables will be studied in terms of incidence of surgical site events, stay, etc.

Interventions

DEVICENegative-pressure wound therapy (PICO)

After the selection of patients and the signing of the consent, patients will be randomized and the device will be placed to those who belong to the PICO group in the operating room.

Sponsors

Hospital Universitario Virgen de la Arrixaca
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

After signing the informed consent of those patients who meet the inclusion criteria, they will be randomized into two groups to install the PICOⓇ device or conventional dressings over the wound. After 7 days, the PICOⓇ device will be removed and both preoperative and postoperative variables will be studied.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients of both sexes aged between 18 and 70 years included in the waiting list for liver transplantation by the committee of the Virgen de la Arrixaca University Hospital.

Exclusion criteria

* To have been rejected for liver transplantation by said committee

Design outcomes

Primary

MeasureTime frameDescription
Incidence rate of surgical site30 days after surgeryAny complication of surgical site will be registered

Secondary

MeasureTime frameDescription
Quality of life of transplantation patient6 monthsWe will use Cardiff Wound Impact Schedule to evaluate the possible improvement in the quality of life of transplantation patients derived from the decrease in the requirement of health resources.
Nosocomial infection rate30 days after surgery (3rd, 7th, 15th and 30th post trasplant)To verify the change in rates of nosocomial infections in the context of liver transplantation.

Countries

Spain

Contacts

Primary ContactVíctor López López
victorrelopez@gmail.com+34 637519516
Backup ContactAna Delegido García
ana.delegido.garcia@gmail.com+ 34 686556188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026